Visiting Professor

Mo is a science entrepreneur with over 30 years’ experience in the pharmaceutical industry, having responsibilities as wide-ranging as R&D and innovation, business development and strategic alliances at Pharmidex. He was previously head of drug metabolism, DMPK/PD at Vernalis Research, before which he was DMPK team leader at Aventis Pharma (Sanofi). Mo is visiting Professor at University of Hertfordshire and a fellow of the Royal Society of Chemistry (FRSC) and the Royal Society for Medicine (FRSM).